Generation Bio Co.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2041
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
- 3 of the patents on this record were granted since Aug 23, 2026
- Sep 29 US 12,746,209 Stealth Lipid Nanoparticle Compositions for Cell Targeting
- Sep 15 US 12,734,249 Lipids and Compositions Thereof
- Sep 8 US 12,729,386 Compositions and Production of Nicked Closed-Ended DNA Vectors
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,252,470 | Novel Lipids and Nanoparticle Compositions Thereof In force · High confidence | In force | High confidence | |
| US 12,534,435 | Novel Lipids and Nanoparticle Compositions Thereof In force · High confidence | In force | High confidence | |
| US 12,442,015 | Closed-Ended DNA Vectors Obtainable from Cell-Free Synthesis and Process for Obtaining Cedna Vectors In force · High confidence | In force | High confidence | |
| US 12,338,275 | Non-viral DNA vectors and uses thereof for expressing FVIII therapeutics In force · USPTO record | In force | USPTO record | |
| US 12,415,002 | Non-viral DNA vectors and uses thereof for expressing phenylalanine hydroxylase (PAH) therapeutics In force · USPTO record | In force | USPTO record | |
| US 12,729,386 | Compositions and Production of Nicked Closed-Ended DNA Vectors In force · High confidence | In force | High confidence | |
| US 12,577,573 | Synthetic Production of Single-Stranded Adeno Associated Viral DNA Vectors In force · High confidence | In force | High confidence | |
| US 12,453,706 | Bispecific Stealth Lipid Nanoparticle Compositions for Cell Targeting In force · Low confidence | In force | Low confidence | |
| US 12,746,209 | Stealth Lipid Nanoparticle Compositions for Cell Targeting In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 9: 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 pending · 10 abandoned · 18 no status recorded
Showing 1 to 10 of 37, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/214,171 | May 21, 2025 | No status recorded | |
| 19/063,950 | Stealth Lipid Nanoparticle Compositions for Cell Targeting | Feb 26, 2025 | Pending |
| 19/063,444 | Lipids and Compositions Thereof | Feb 26, 2025 | Pending |
| 19/042,351 | Lipids and Nanoparticle Compositions Thereof | Jan 31, 2025 | Pending |
| 18/792,148 | Identifying and Characterizing Genomic Safe Harbors (GSH) in Humans and Murine Genomes, and Viral and Non-Viral Vector Compositions for Targeted Integration at an Identified GSH Loci | Aug 1, 2024 | Pending |
| 18/871,840 | Lipid Nanoparticle Compositions and Uses Thereof | Jun 7, 2023 | Pending |
| 18/722,701 | Scalable and High-Purity Cell-Free Synthesis of Closed-Ended DNA Vectors | Dec 22, 2022 | Pending |
| 18/690,020 | Sep 16, 2022 | No status recorded | |
| 18/578,073 | Jul 13, 2022 | No status recorded | |
| 18/569,623 | Cationic Lipids and Compositions Thereof | Jun 14, 2022 | Pending |
10 of 37 applications shown.
Pro members see all 37 published applications.